PHG secures FDA nod for AI-powered EchoNavigator R5.0, boosts its push into minimally invasive heart repair and expands U.S. market reach.

The astronaut who prompted NASA's first medical evacuation earlier this year says doctors still don't know why he suddenly ...

Philips has secured an FDA clearance for its artificial intelligence program that tracks and guides the placement of a ...

IntraSight Plus merges Philips’ technologies, offering co-registration, iFR/FFR physiology, and real-time device ...

Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its EchoNavigator R5.0 with DeviceGuide.

Philips’ DeviceGuide uses AI to track and visualise mitral valve replacement devices during mitral regurgitation procedures.

Philips said Thursday it has received 510(k) clearance for a heart procedure visualization tool it developed with Edwards ...

March 26, 2026Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive ...

A team at Helmholtz Munich and the Technical University of Munich (TUM) has developed a new microscopy technique that can ...

March 25, 2026Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help ...

Philips (NYSE:PHG) today announced the launch of its IntraSight Plus interventional guidance platform in the U.S. and Europe.

Portal hypertension (PH), a serious complication of liver cirrhosis, is defined as a pressure gradient > 5 mmHg between the portal vein and the inferior vena cava.